Clarus Therapeutics Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, and Blue Water Acquisition Corp., a special purpose acquisition company (SPAC) ...
Lipocine Inc., a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced that Judge William C. Bryson of the United States District Court of Delaware has postponed the February 8, 2021 jury trial scheduled to ...